Global Seizures API Manufacturers, Marketed and Phase III Drugs Landscape Report, 2019-2021 - ResearchAndMarkets.com

January 31, 2019

DUBLIN--(BUSINESS WIRE)--Jan 31, 2019--The “Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019″ report provides comprehensive insights about marketed and Phase III products for Seizures . The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country.

Coverage of API manufacturers for Seizures marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.

This report provides a comprehensive understanding of the emerging Phase III therapies for Seizures which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2021.

Key Topics Covered:

1. Report Introduction

2. Seizures: Overview

Risk Factors Causes Symptoms Pathophysiology Prognosis Diagnosis Treatment

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

Product Description Route of Synthesis Mechanism of Action Pharmacology Pharmacodynamics Pharmacokinetics Adverse Reactions Clinical Trials Regulatory Milestones Product Development Activities United States Europe Global Sales Assessment Historical Global Sales Forecasted Global Sales Patent Details

5. Emerging Therapies (Phase III)

Product Description Research and Development Product Development Activities Forecasted Global Sales Other Phase III profiles

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/njspfb/global_seizures?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190131005790/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

PUB: 01/31/2019 01:17 PM/DISC: 01/31/2019 01:17 PM

http://www.businesswire.com/news/home/20190131005790/en